Physician profile
Daniel J Huff
NPI 1437364445
$2,191.83
in general payments reported to CMS, 2019-2025
32 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $589 · 2021: $132 · 2022: $372 · 2023: $266 · 2024: $359 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $425.15 | 2020-2023 | |
| Abbott Laboratories | $310.67 | 2021-2022 | |
| Stryker Corporation | $283.78 | 2019-2024 | Augment Injectable, Easyfuse |
| Averitas Pharma INC. | $145.89 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $112.97 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $101.50 | 2024 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $96.24 | 2023-2025 | Nuzyra |
| Abbvie INC. | $68.36 | 2022-2024 | |
| Organogenesis INC. | $61.83 | 2019-2024 | Puraply |
| Zyla Life Sciences, INC. | $50.20 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $46.62 | 2025 | Purified Cortrophin Gel |
| Paragon 28, INC. | $41.54 | 2019-2025 | Gorilla, Precision Mis Bunion |
| Aroa Biosurgery Incorporated | $40.55 | 2022-2023 | |
| Smith+Nephew, INC. | $39.69 | 2021-2023 | Grafix Pl |
| Solventum Corporation | $38.76 | 2024 | Activ.A.C. |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $37.58 | 2021 | |
| Zimmer Biomet Holdings, INC. | $35.52 | 2019 | |
| Horizon Therapeutics Plc | $34.35 | 2023 | Krystexxa |
| Kci USA, INC. | $24.87 | 2021 | |
| Djo, LLC | $24.18 | 2019 | |
| Bioventus LLC | $20.95 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.06 | 2025 | Journavx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.42 | 2023 | Jublia |
| Treace Medical Concepts, INC. | $15.02 | 2024 | |
| Grt US Holding, INC. | $14.78 | 2022 | |
| Urgo Medical North America, LLC | $14.76 | 2024 | Urgok2 |
| Nalu Medical, INC. | $14.57 | 2022 | |
| Medtronic, INC. | $14.19 | 2025 | Inceptiv |
| Arthrosurface Incorporated | $13.32 | 2019 | |
| Globus Medical, INC. | $11.81 | 2022 | |
| Integra Lifesciences Corporation | $11.07 | 2019 | |
| Curonix LLC | $8.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.